These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6889423)

  • 1. Oral absorption of bendazac lysine salt in man after repeated administrations.
    Barillari G; Iorio E; Galli Angeli D; Catanese B
    Pharmacol Res Commun; 1983 May; 15(5):461-71. PubMed ID: 6889423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the oral absorption in man of bendazac and its lysine salt.
    Catanese B; Barillari G; Iorio E; Silvestrini B
    Boll Chim Farm; 1982 Feb; 121(2):87-90. PubMed ID: 7126348
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of Lonidamine after oral administration in cancer patients.
    Besner JG; Leclaire R; Band PR; Deschamps M; De Sanctis AJ; Catanese B
    Oncology; 1984; 41 Suppl 1():48-52. PubMed ID: 6717895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution, urinary, fecal and biliary excretion of 14C bendazac L-lysine salt in rats.
    Catanese B; Valeri P; Durando L; Gismondi A
    Pharmacol Res Commun; 1985 May; 17(5):425-32. PubMed ID: 4034626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of bendazac-lysine and 5-hydroxybendazac, its main metabolite, in patients with hepatic cirrhosis.
    Rovei V; Escourrou J; Campistron G; Ego D; Thiola A; Ribet A; Houin G
    Eur J Clin Pharmacol; 1988; 35(4):391-6. PubMed ID: 3197747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on the ocular pharmacokinetics of bendazac in rabbits.
    Valeri P; Palmery M; Tita B; Silvestrini B
    Exp Mol Pathol; 1985 Dec; 43(3):283-7. PubMed ID: 4065307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic data supporting the use of the l-lysine salt of bendazac in cataract.
    Silvestrini B; Catanese B; Barillari G; Iorio E; Valeri P
    Int J Tissue React; 1983; 5(2):217-25. PubMed ID: 6618787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the activity of Bendalina (bendazac L-lysine salt) as a scavenger of hydroxyl and superoxide radicals.
    Schmut O; Hofmann H
    Wien Klin Wochenschr; 1985 Nov; 97(21):819-22. PubMed ID: 2998102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels and metabolism of bendazac lysine salt in man.
    Catanese B; Barillari G; Picollo R; Corradino C
    Boll Chim Farm; 1986 Aug; 125(8):298-302. PubMed ID: 3814364
    [No Abstract]   [Full Text] [Related]  

  • 10. [Absorption, metabolism and excretion of 2-methyl-3-methylamino-4,5,6,7-tetrahydroindazole (tetridamine) in the rat].
    Massaroli G; Cellari C; Coerezza M; Scuri R
    Boll Chim Farm; 1972 Nov; 111(11):649-57. PubMed ID: 4655669
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of the scavenger-like activity of bendazac.
    Musci G; Silvestrini B
    Drugs Exp Clin Res; 1987; 13(5):289-92. PubMed ID: 3678037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A metabolite of bendazac].
    Giannangeli M; Interdonato N; Baiocchi L
    Boll Chim Farm; 1982 Sep; 121(9):465-74. PubMed ID: 7159511
    [No Abstract]   [Full Text] [Related]  

  • 13. Absorption of bendazac lysine after topical application to the rabbit eye.
    Valeri P; Palmery M; Martinelli B; Catanese B
    Pharmacol Res Commun; 1987 Aug; 19(8):517-25. PubMed ID: 3432319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiency.
    Rovei V; Campistron G; Dueymes JM; Ego D; Conte JJ; Houin G
    Eur J Clin Pharmacol; 1987; 33(3):303-10. PubMed ID: 3691618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous absorption of benzydamine in guinea pig and man.
    Andersson K; Larsson H
    Arzneimittelforschung; 1974 Oct; 24(10):1686-8. PubMed ID: 4479782
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of bendazac lysine on lens and retina in diabetics.
    Benitez del Castillo JM; Jimenez-Alfaro I; Ortega P; Castillo A; Diaz D; Toledano N; Garcia-Sanchez J
    Doc Ophthalmol; 1994; 86(4):387-93. PubMed ID: 7835176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bendazac lysine. A review of its pharmacological properties and therapeutic potential in the management of cataracts.
    Balfour JA; Clissold SP
    Drugs; 1990 Apr; 39(4):575-96. PubMed ID: 2190795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bendazac lysine in selected types of human senile cataract. A long-term double-masked placebo-controlled clinical trial with multilinear densitometric image analysis of Scheimpflug photographs.
    Hockwin O; Laser H; De Gregorio M; Carrieri MP
    Ophthalmic Res; 1989; 21(3):141-54. PubMed ID: 2674821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bendazac L-lysine salt on some metabolic enzymes of glutathione in the rabbit lens after X-irradiation.
    Bono A; Militello A; Bongiorno A; Livrea MA; Pandolfo L
    Ital J Biochem; 1987; 36(3):153-65. PubMed ID: 3610598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of rat lens aldose reductase by bendazac-L-lysine salt.
    Iuliano G; Menzione M; Apponi-Battini G; Costagliola C
    Enzyme; 1989; 42(4):235-7. PubMed ID: 2517113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.